Skeletal muscle differentiation of mesodermal ipsc derived progenitors KU Leuven
The present invention relates to in vitro methods to increase the myogenic potential of mesodermal IPSC derived progenitors of fibroblast origin, by administering compounds which induce pro-myogenic genes or administering compounds which inhibit anti-myogenic genes.